alpha-msh and Obesity

alpha-msh has been researched along with Obesity* in 1 studies

Other Studies

1 other study(ies) available for alpha-msh and Obesity

Article	Year
Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist. Bioorganic & medicinal chemistry letters, 2005, Jan-03, Volume: 15, Issue:1 We report the discovery and optimization of substituted 2-piperazinecarboxamides as potent and selective agonists of the melanocortin subtype-4 receptor. Further in vivo development of lead agonist, MB243, is disclosed. Topics: Animals; Dogs; Erectile Dysfunction; Haplorhini; Male; Mice; Obesity; Piperazines; Piperidines; Rats; Receptor, Melanocortin, Type 4	2005

Article

Year

Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist.

Bioorganic & medicinal chemistry letters, 2005, Jan-03, Volume: 15, Issue:1

We report the discovery and optimization of substituted 2-piperazinecarboxamides as potent and selective agonists of the melanocortin subtype-4 receptor. Further in vivo development of lead agonist, MB243, is disclosed.

Topics: Animals; Dogs; Erectile Dysfunction; Haplorhini; Male; Mice; Obesity; Piperazines; Piperidines; Rats; Receptor, Melanocortin, Type 4

2005